scispace - formally typeset
K

Kazuo Takayama

Researcher at Kyoto University

Publications -  128
Citations -  3501

Kazuo Takayama is an academic researcher from Kyoto University. The author has contributed to research in topics: Induced pluripotent stem cell & Medicine. The author has an hindex of 25, co-authored 103 publications receiving 2293 citations. Previous affiliations of Kazuo Takayama include Osaka University & National Presto Industries.

Papers
More filters
Journal ArticleDOI

3D spheroid culture of hESC/hiPSC-derived hepatocyte-like cells for drug toxicity testing

TL;DR: A hepatocyte differentiation method that employs not only stage-specific transient overexpression of hepatocyte-related transcription factors but also a three-dimensional spheroid culture system using a Nanopillar Plate is established that could generate more matured hepatocytes-like cells than the previous protocol.
Journal ArticleDOI

Efficient Generation of Functional Hepatocytes From Human Embryonic Stem Cells and Induced Pluripotent Stem Cells by HNF4α Transduction

TL;DR: The method would be a valuable tool for the efficient generation of functional hepatocytes derived from human ESCs and iPSCs, and the hepatocyte-like cells could be used for predicting drug toxicity and could catalyze the toxication of several compounds.
Journal ArticleDOI

Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes

TL;DR: It is found that cytochrome P450 metabolism capacity and drug responsiveness of the primary human hepatocytes–human induced pluripotent stem cells–hepatocyte-like cells (PHH-iPS-HLCs) were highly correlated with those of PHHs, suggesting that the PHH- iPS- HLCs retained donor-specific CYP metabolism capacityand drug responsiveness.
Journal ArticleDOI

Generation of metabolically functioning hepatocytes from human pluripotent stem cells by FOXA2 and HNF1α transduction

TL;DR: The method employing the transduction of FOXA2 and HNF1α represents a useful tool for the efficient generation of metabolically functional hepatocytes from hESCs and hiPSCs, and the screening of drug-induced cytotoxicity.
Journal ArticleDOI

In Vitro and Animal Models for SARS-CoV-2 research.

TL;DR: Here, it is briefly reviewed the cell lines, organoids, and animal models that are currently being used in COVID-19 research.